LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/How Much Pent-Up Demand Exists for Joint Arthroplasty?
Large Joints and Extremities

How Much Pent-Up Demand Exists for Joint Arthroplasty?

February 18, 2019 2 min read Premium comments

Advertisement

How Much Pent-Up Demand Exists for Joint Arthroplasty?
Source: Wikimedia Commons and Jocelyn Augustino
#jointreplacement#totaljointarthroplastySecondary#medicare

Are patients waiting until Medicare kicks in to ask for total joint arthroplasty (TJA)? And, if so, how large is that pent-up demand?

Those are the questions that a group of Mayo Clinic researchers tackled with new research that has just been published in the February 2019 edition of the Journal of Arthroplasty. The title of the new study is “Evidence of Pent-Up Demand for Total Hip and Total Knee Arthroplasty at Age 65.”

Co-author Adam J. Schwartz, M.D., M.B.A., an assistant professor of Orthopaedic Surgery at the Mayo Clinic College of Medicine in Phoenix, Arizona, outlined the background of his study to OTW. “We see a number of patients who are age 65, just getting onto Medicare as their primary health plan, and we asked if a large proportion of these patients might have had their surgery earlier if they had appropriate coverage.”

“A large number of patients seem to wait for Medicare enrollment before deciding to have a joint replacement. Policy makers need to understand the additional financial burden that the public health care system assumes because under-insured patients wait until Medicare enrollment to have their total joint replacement. This is in addition to the added years of pain and disability endured by patients who cannot proceed with the surgery until it becomes affordable to do so.”

Schwartz and his colleagues used the 2014 Nationwide Readmission Database to determine the incidence of TJA. What they found was that the TJA incidence rates increased from age 64 to 65 as compared to the expected increase.

The researchers calculated pent-up demand by subtracting the expected from the observed difference in frequency of TJA. They also measured the costs of such pent-up demand. The authors determined excess cost by multiplying this value by the median cost of a primary TJA. They then used the Medicare Expenditure Panel Survey Household Component to compare out-of-pocket costs, access to care, and insurance coverage among patients aged 60-64 (group 1) and 66-70 (group 2).

According to Schwartz and his colleagues, “The expected and observed increases in TJA procedures from age 64 to 65 were 595 and 5,211, respectively, resulting in pent-up demand of 4,616 joint arthroplasties (1,273 THA and 3,343 TKA), and an excess cost of $55 million (range, $33 million-$70 million). Mean total out-of-pocket expenses for patients in group 1 were significantly greater ($1,578.39) than patients in group 2…”

“Understand that as your patients get closer to enrolling in Medicare, they are more likely to defer their surgery. There is a slowing in demand for joint replacement around age 63, 64, when patients approach enrollment. It is reasonable to explore these issues with patients and try to understand their concerns and some of the issues with their insurance companies. It is quite possible that they do not need to unnecessarily delay these needed procedures.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy